Evidence map›Paper›PMID 16018579›Full record

ArticleNeurochemical research2005

Cellular death in hippocampus in response to PI3K pathway inhibition and oxygen and glucose deprivation.

Ana Paula Horn, Daniéli Gerhardt, Augusto Bencke Geyer, Lauren Valentim, Helena Cimarosti, Alexandre Tavares, Fabiana Horn, Guido Lenz, Christianne Salbego

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ana Paula HornDepartamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, RS, Brazil.
Daniéli Gerhardt
Augusto Bencke Geyer
Lauren Valentim
Helena Cimarosti
Alexandre Tavares
Fabiana Horn
Guido Lenz
Christianne Salbego
Universidade Federal do Rio Grande do Sul · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the importance of the phosphoinositide3-kinase (PI3K) pathway in CA1 and dentate gyrus (DG) areas of hippocampus by exposing organotypic cultures to LY294002, a PI3K inhibitor, or to oxygen and glucose deprivation (OGD) for up to 21 hours. LY294002 induced increased propidium iodide (PI) uptake and caspase 3/7 activity in both regions, with a faster onset in DG. In contrast, cultures exposed to 60 min of OGD showed a PI uptake only in the CA1 area, beginning 13 h after the insult and increasing until 21 h. We did not observe any significant changes in AKT phosphorylation and immunocontent in CA1 or DG areas of organotypic cultures exposed to OGD, suggesting that the phosphorylation of this protein at Ser-473 is unrelated to the cellular damage induced by ischemia. Our results suggest that the inhibition of the PI3K pathway does not mimic the cell death profile observed with an ischemic model.

Indexed as

Phosphoinositide-3 Kinase InhibitorsAnimalsApoptosisBlotting, WesternCaspasesCell DeathCells, CulturedChromonesEnzyme ActivationEnzyme InhibitorsGlucoseHippocampusHypoxiaMorpholinesOncogene Protein v-aktPhosphorylation2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneCaspasesChromonesEnzyme InhibitorsGlucoseMorpholinesOncogene Protein v-aktPhosphoinositide-3 Kinase InhibitorsRetroviridae Proteins, Oncogenic

Identifiers

PMID16018579
OpenAlexW2052359737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.